Indaptus Therapeutics
INDP----
Indaptus Therapeutics (INDP)
Indaptus Therapeutics, Inc., a clinical biotechnology company, engages in the development of various anti-cancer and anti-viral immunotherapy products. Its lead...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Indaptus Therapeutics Analyst Rating
View MoreForecast & Rating
Nov 12, 2025Price forecast
$10.00283.14%
Forecast & RatingBuy
1analysts
- Strong buy0.00%
- Buy100.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Market Beat · Jul 12 at 10:40 PM
Indaptus Therapeutics, Inc. (NASDAQ:INDP) Sees Large Decrease in Short Interest
- Simplywall · Jul 8 at 06:57 AM
Insider Traders Lose US$34k As Indaptus Therapeutics Drops
- PUBT · Jun 24 at 03:02 PM
Indaptus Therapeutics sells 20,000,000 shares at $0.6 in $12 million private placement
- benzinga_article · Jun 10 at 12:05 PM
12 Health Care Stocks Moving In Wednesday's Intraday Session
- Price Alert · Jun 9 at 07:30 PM
U.S. stock night market fluctuations: INDP rose 3.21% in the night market, with active capital and increased volatility; subsequent trends await observation
- benzinga_article · Jun 8 at 07:06 AM
12 Health Care Stocks Moving In Monday's Pre-Market Session
